Buhisan, May Ann .

HRN: 04-00-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
AMPICILLIN 1GM (VIAL)
06/26/2024
06/28/2024
IV
2gm
Q6
Prom
Waiting Final Action 
06/26/2024
CEFUROXIME 500MG (TAB)
06/26/2024
07/03/2024
PO
500mg Tab
BID
Prom X 7 Hrs; S/P NSVD With RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: